Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

  • Susan N. Chi
  • , Joanna S. Yi
  • , P. Mickey Williams
  • , Sinchita Roy-Chowdhuri
  • , David R. Patton
  • , Brent D. Coffey
  • , Joel M. Reid
  • , Jin Piao
  • , Lauren Saguilig
  • , Todd A. Alonzo
  • , Stacey L. Berg
  • , Nilsa C. Ramirez
  • , Alok Jaju
  • , Joyce C. Mhlanga
  • , Elizabeth Fox
  • , Douglas S. Hawkins
  • , Margaret M. Mooney
  • , Naoko Takebe
  • , James V. Tricoli
  • , Katherine A. Janeway
    • Nita L. Seibel, D. Williams Parsons

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science